These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 21539538)

  • 21. Association between liver fibrosis and insulin sensitivity in chronic hepatitis C patients.
    Taura N; Ichikawa T; Hamasaki K; Nakao K; Nishimura D; Goto T; Fukuta M; Kawashimo H; Fujimoto M; Kusumoto K; Motoyoshi Y; Shibata H; Abiru N; Yamasaki H; Eguchi K
    Am J Gastroenterol; 2006 Dec; 101(12):2752-9. PubMed ID: 17026566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adiponectin and its receptors in patients with chronic hepatitis C.
    Jonsson JR; Moschen AR; Hickman IJ; Richardson MM; Kaser S; Clouston AD; Powell EE; Tilg H
    J Hepatol; 2005 Dec; 43(6):929-36. PubMed ID: 16139921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liver microsomal triglyceride transfer protein is involved in hepatitis C liver steatosis.
    Mirandola S; Realdon S; Iqbal J; Gerotto M; Dal Pero F; Bortoletto G; Marcolongo M; Vario A; Datz C; Hussain MM; Alberti A
    Gastroenterology; 2006 May; 130(6):1661-9. PubMed ID: 16697730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of metabolic profiles with hepatic fibrosis in chronic hepatitis C patients with genotype 1 or 2 infection.
    Hsu CS; Liu CH; Liu CJ; Hsu SJ; Chen CL; Hwang JJ; Lai MY; Chen PJ; Chen DS; Kao JH
    J Gastroenterol Hepatol; 2010 May; 25(5):970-7. PubMed ID: 20546452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C.
    Miquilena-Colina ME; Lima-Cabello E; Sánchez-Campos S; García-Mediavilla MV; Fernández-Bermejo M; Lozano-Rodríguez T; Vargas-Castrillón J; Buqué X; Ochoa B; Aspichueta P; González-Gallego J; García-Monzón C
    Gut; 2011 Oct; 60(10):1394-402. PubMed ID: 21270117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum lipid pattern in chronic hepatitis C: histological and virological correlations.
    Siagris D; Christofidou M; Theocharis GJ; Pagoni N; Papadimitriou C; Lekkou A; Thomopoulos K; Starakis I; Tsamandas AC; Labropoulou-Karatza C
    J Viral Hepat; 2006 Jan; 13(1):56-61. PubMed ID: 16364083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adiponectin levels and insulin resistance among patients with chronic hepatitis C.
    Carvalho RF; Atta AM; de Oliveira IS; Santos TPS; Santos JPA; Schinoni MI; de Sousa-Atta MLB
    Acta Trop; 2018 Feb; 178():258-263. PubMed ID: 29217381
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adiponectin and its receptors in chronic hepatitis B patients with metabolic syndrome in China.
    Li X; Ren N; Ling W; Chen F; Zhang W; Fan X; Tian M; Zhang T; Li B; Pfeffer LM; Wu H; Zhang J
    Hepatogastroenterology; 2012 Sep; 59(118):1735-43. PubMed ID: 22819899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C.
    Cammà C; Bruno S; Di Marco V; Di Bona D; Rumi M; Vinci M; Rebucci C; Cividini A; Pizzolanti G; Minola E; Mondelli MU; Colombo M; Pinzello G; Craxì A
    Hepatology; 2006 Jan; 43(1):64-71. PubMed ID: 16374856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic syndrome, insulin resistance and adiponectin level in patients with chronic hepatitis C.
    Grigorescu M; Radu C; Crişan D; Grigorescu MD; Serban A; Neculoiu D; Rusu M; Acalovschi M
    J Gastrointestin Liver Dis; 2008 Jun; 17(2):147-54. PubMed ID: 18568135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Normal adiponectin levels despite abnormal glucose tolerance (or diabetes) and inflammation in adult patients with cystic fibrosis.
    Hammana I; Malet A; Costa M; Brochiero E; Berthiaume Y; Potvin S; Chiasson JL; Coderre L; Rabasa-Lhoret R
    Diabetes Metab; 2007 Jun; 33(3):213-9. PubMed ID: 17418606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interplay between oxidative stress and hepatic steatosis in the progression of chronic hepatitis C.
    Vidali M; Tripodi MF; Ivaldi A; Zampino R; Occhino G; Restivo L; Sutti S; Marrone A; Ruggiero G; Albano E; Adinolfi LE
    J Hepatol; 2008 Mar; 48(3):399-406. PubMed ID: 18164507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of renal transplantation on adiponectin and its isoforms and receptors.
    Shen YY; Charlesworth JA; Kelly JJ; Peake PW
    Metabolism; 2007 Sep; 56(9):1201-8. PubMed ID: 17697862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High molecular weight adiponectin correlates with insulin sensitivity in patients with hepatitis C genotype 3, but not genotype 1 infection.
    Wang AY; Hickman IJ; Richards AA; Whitehead JP; Prins JB; Macdonald GA
    Am J Gastroenterol; 2005 Dec; 100(12):2717-23. PubMed ID: 16393225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of insulin resistance on adiponectin receptor expression in breast cancer.
    Pfeiler G; Treeck O; Wenzel G; Goerse R; Hartmann A; Schmitz G; Ortmann O
    Maturitas; 2009 Jul; 63(3):253-6. PubMed ID: 19524379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adiponectin: a new independent predictor of liver steatosis and response to IFN-alpha treatment in chronic hepatitis C.
    Zografos TA; Liaskos C; Rigopoulou EI; Togousidis E; Makaritsis K; Germenis A; Dalekos GN
    Am J Gastroenterol; 2008 Mar; 103(3):605-14. PubMed ID: 18190648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genotype-specific interactions of insulin resistance, steatosis, and fibrosis in chronic hepatitis C.
    Cua IH; Hui JM; Kench JG; George J
    Hepatology; 2008 Sep; 48(3):723-31. PubMed ID: 18688878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential role of bcl-2 and bax mRNA and protein expression in chronic hepatitis type B and C: a clinicopathologic study.
    Tsamandas AC; Thomopoulos K; Zolota V; Kourelis T; Karatzas T; Ravazoula P; Tepetes K; Petsas T; Karavias D; Karatza C; Bonikos DS; Gogos C
    Mod Pathol; 2003 Dec; 16(12):1273-88. PubMed ID: 14681329
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum HCV RNA levels and HCV genotype do not affect insulin resistance in nondiabetic patients with chronic hepatitis C: a multicentre study.
    Tsochatzis E; Manolakopoulos S; Papatheodoridis GV; Hadziyannis E; Triantos C; Zisimopoulos K; Goulis I; Tzourmakliotis D; Akriviadis E; Manesis EK; Archimandritis AJ
    Aliment Pharmacol Ther; 2009 Nov; 30(9):947-54. PubMed ID: 19604179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin resistance in chronic hepatitis B virus infection.
    Kumar M; Choudhury A; Manglik N; Hissar S; Rastogi A; Sakhuja P; Sarin SK
    Am J Gastroenterol; 2009 Jan; 104(1):76-82. PubMed ID: 19098853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.